Both substances can cause gastrointestinal symptoms including nausea, vomiting, and diarrhoea, which might potentially intensify when combined
He sheds light on how the Watchman Implant is transforming the lives of those living with NVAFib, including many of our Connected Cardiovascular Care patients.
Option 3: Switching to Tirzepatide Another option for patients who are not achieving their weight loss goals on certain GLP-1s, like Semaglutide, is switching to Tirzepatide, a newer dual-action GLP-1 and GIP receptor agonist that has shown more impressive weight loss results in recent clinical trials
Heather Martin, a family medicine physician based in Tennessee
Those with a personal or family history of medullary thyroid cancer Those that are pregnant Those that are breastfeeding How can I get a Wegovy prescription online in Canada